About

Thierry Langer, Pharm MS, PhD, joined Prestwick Chemical, Inc. in April 2008. His previous employment had been Professor at Leopold-Franzens-University of Innsbruck, Austria, where he began his career after completing a postdoctoral fellowship at the Universite Louis Pasteur (Strasbourg, France) with Prof. C. G. Wermuth in 1992. Prof. Langer holds an M.S. degree in Pharmacy (1988) and a Ph.D. (Medicinal Chemistry, 1991) from the University of Vienna, Austria. In 2003, together with Prof. Stuppner and Dr. Wolber (University of Innsbruck, Austria) he founded the spin-off company Inte:Ligand GmbH, in which he also was CEO prior to joining Prestwick Chemical, Inc. His research interests have been focused on computer-assisted medicinal chemistry, including pharmacophore-based methods as well as 3D-QSAR molecular modelling techniques. Since 1993 he established at Innsbruck University the Computer Aided Molecular Design Group, was appointed Associate Professor of Pharmaceutical Chemistry in 1997, and served as Head of the Institute of Pharmaceutical Chemistry and of the Pharmaceutical Chemistry Department in 1998 and 1999. Prof. Langer is a well known scientist in the field of computer aided molecular design: He published more than 150 original articles and invited reviews in peer reviewed journals, several book chapters, one edited book, and more than 200 presentations at scientific meetings. Since October 2013 he is Professor of Pharmaceutical Chemistry at the Department of Pharmaceutical Chemistry, University of Vienna

Main research fields:

Computer Aided Molecular Design:

• Pharmacophore Modelling for Parallel In Silico Screening and Drug Discovery
• Software Design for Computer-Assisted Ligand Design and Drug Discovery
• Generation and Screening of Virtual 3-D Molecular Libraries
• 3D-QSAR (CoMFA, CoMSIA): Classical and Novel Applications